Ganoderma lucidum 'Huang Zhi'

Ganoderma lucidum 'Huang Zhi' is a yellow-colored variety of reishi mushroom containing polysaccharides and triterpenes as primary bioactive compounds. Traditional Chinese medicine attributes immune-supporting and longevity properties to this variant, though clinical evidence remains limited.

Origin & History

Ganoderma lucidum 'Huang Zhi' is a specific cultivar variant of the medicinal Reishi mushroom, selectively bred for enhanced medicinal properties and native to East Asia. The fruiting body or mycelium is cultivated via solid-state methods (log or sawdust bags) or liquid-state fermentation, with extraction using dynamic forced circulation improving yields by approximately 37.5% over traditional methods.

Historical & Cultural Context

Ganoderma lucidum variants including 'Huang Zhi' have been used in Traditional Chinese Medicine as 'Lingzhi' for over 2,000 years, historically documented for promoting longevity, immunity, and vitality. Modern cultivation methods replicate traditional log-based practices from ancient Chinese agricultural techniques.

Health Benefits

• No clinical evidence for health benefits available - research focuses solely on cultivation and extraction methods
• Traditional use suggests immune support - no clinical trials found in research dossier
• Historical claims of longevity promotion - no human studies provided
• Polysaccharide content (68.5 g/kg in dry powder) suggests potential bioactivity - no clinical validation
• Ganoderic acid production (582 mg/L) indicates therapeutic compounds present - human efficacy unverified

How It Works

The polysaccharides in Ganoderma lucidum 'Huang Zhi' are theorized to modulate immune function through activation of macrophages and natural killer cells via toll-like receptor pathways. Triterpene compounds may influence liver metabolism and contribute to adaptogenic effects through hypothalamic-pituitary-adrenal axis modulation. These mechanisms are based on general reishi research, as specific studies on the 'Huang Zhi' variant are lacking.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were found in the research dossier for Ganoderma lucidum 'Huang Zhi' or general G. lucidum. The available research focuses exclusively on cultivation techniques and extraction optimization without providing clinical evidence or PubMed PMIDs.

Clinical Summary

No specific clinical trials have been conducted on Ganoderma lucidum 'Huang Zhi' variant. Available research focuses primarily on cultivation techniques and extraction methods rather than therapeutic applications. Traditional use documentation suggests historical applications for immune support and longevity, but these claims lack validation through controlled human studies. The evidence base remains entirely preclinical with no quantified health outcomes available.

Nutritional Profile

Ganoderma lucidum 'Huang Zhi' dry powder contains high polysaccharide content at 68.5 g/kg (6.85%), predominantly beta-glucans (beta-1,3 and beta-1,6 linkages) which are the primary bioactive fraction. Ganoderic acids (triterpenoids) are present, with total triterpene content typically ranging 10–40 mg/g in dried Ganoderma material; specific quantification for 'Huang Zhi' strain not established in available data. Protein content in dried Ganoderma lucidum generally ranges 10–18% dry weight, containing essential amino acids including lysine, leucine, and valine, though bioavailability is reduced by the chitin-rich cell wall matrix. Dietary fiber (chitin and beta-glucans combined) typically constitutes 50–80% of dry weight in Ganoderma species. Fat content is low, generally 1–3% dry weight, with ergosterol (provitamin D2 precursor) present at approximately 0.3–0.8 mg/g dry weight, convertible to vitamin D2 upon UV exposure. Mineral content includes potassium (~3–8 mg/g), phosphorus (~2–5 mg/g), magnesium (~0.5–2 mg/g), calcium, zinc, and selenium in trace amounts. Adenosine and other nucleosides contributing to bioactivity are present at low concentrations (<1 mg/g). Bioavailability note: intact cell wall chitin significantly limits nutrient and polysaccharide absorption; hot-water or dual (water/ethanol) extraction markedly improves polysaccharide and ganoderic acid bioavailability compared to raw powder consumption. Strain-specific data for 'Huang Zhi' beyond polysaccharide content (68.5 g/kg) is not established in current research literature.

Preparation & Dosage

No clinically studied dosage ranges are available from the research. Production yields include 22.1 g/L biomass, 1.71-2.49 g/L polysaccharides, and 582 mg/L ganoderic acids from fermentation, but these are production values, not therapeutic doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other Reishi variants, Cordyceps, Turkey Tail, Vitamin D3, Astragalus

Safety & Interactions

Safety data specific to Ganoderma lucidum 'Huang Zhi' is not available in clinical literature. General reishi mushroom safety profiles suggest potential for mild digestive upset, dizziness, and skin reactions in sensitive individuals. Possible interactions with anticoagulant medications due to triterpene content, though specific drug interaction studies are lacking. Pregnancy and lactation safety has not been established for this particular variant.